Abstract
Protonitazene is a synthetic benzoimidazole opioid of the nitazenes class, developed in the 1950s as an effective analgesic, but never released in the market due to severe side effects and major risk of dependence. The laboratory was involved in the determination of the cause of death for 5 subjects deceased in a French department of the Indian Ocean. The 5 victims were male, aged between 20 and 35 years. The first 2 victims were found dead in their prison cell and the 3 other victims were found dead in a squat. Therefore, we have developed and validated a specific procedure to identify and quantify the drug in post mortem specimens using LC-MS/MS. The procedure involves extraction of 0.5 mL fluid at pH 9.5 with a mixture of organic solvents in presence of 20 ng fentanyl-d5 used as internal standard. Linearity of the method was verified from 0.1 to 20 ng/mL in both whole blood and urine (r2 = 0.9983 and 0.9993, respectively). The limit of detection was estimated at 0.05 ng/mL in each matrix. Protonitazene was identified at < LOQ to 0.8 ng/mL, 0.4 to 2.9 ng/mL and 3.0 to 8.0 ng/mL in femoral blood, urine and bile, respectively. Post mortem concentrations were very low, which is consistent with reported high toxicity of protonitazene. As nitazenes represent a growing threat to public health in various parts of the world, this method seems to be a good response to the challenges posed by the identification of this class of substances.
Similar content being viewed by others
Data availability
The data underlying this article will be shared upon reason- able request to the corresponding author.
References
https://www.cfsre.org/nps-discovery/public-alerts/new-nitazene-analogue-n-pyrrolidino-protonitazene-impacting-drug-markets-in-north-america-and-europe. Accessed 24 April 2024
Schumann JL, Syrjanen R, Alford K, Mashetty S, Castle JW, Rotella J, Maplesden J, Greene SL (2023) Intoxications in an Australian emergency department involving nitazene benzylbenzimidazole synthetic opioids (etodesnitazene, butonitazene and protonitazene). J Anal Toxicol 47:e6–e9
https://www.emcdda.europa.eu/publications/initial-reports/isotonitazene_en. Accessed 24 April 2024
https://addictovigilance.fr/rapports/communique-circulation-des-nitazenes-nouveaux-opioides-de-synthese-et-risque-pour-les-usagers/. Accessed 24 April 2024
Mueller F, Bogdal C, Pfeiffer B, Andrello L, Ceschi A, Thomas A, Grata E (2021) Isotonitazene: fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland. Forensic Sci Int 320:110686
Walton SE, Krotulski AJ, Logan BK (2022) A forward-thinking approach to addressing the new synthetic opioid 2-benzylbenzimidazole nitazene analogs by liquid chromatography-tandem quadrupole mass spectrometry (LC-QQQ-MS). J Anal Toxicol 46:221–231
Pardi J, Ford S, Cooper G (2023) Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City. J Anal Toxicol 47:648–655
Vandeputte MM, Krotulski AJ, Walther D, Glatfelter GC, Papsun D, Walton SE, Logan BK, Baumann MH, Stove CP (2022) Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid. Arch Toxicol 96:1845–1863
Montanari E, Madeo G, Pichini S, Busardo FP, Carlier J (2022) Acute intoxications and fatalities associated with benzimidazole opioid (nitazene analog) use: a systematic review. Ther Drug Monit 44:494–510
Di Trana A, Pichini S, Pacifici R, Giorgetti R, Busardo FP (2022) Synthetic benzimidazole opioids: the emerging challenge for European drug users. Front Psychiatry 13:858234
Edinoff AN, Garza DM, Vinning SP, Vasterling ME, Jackson ED, Murane KS, Kaye AM, Fair RN, Lopez Torres YJ, Badr AE, Cornett EM, Kaye AD (2023) New synthetic opioids: clinical considerations and dangers. Pain Therapy 12:399–421
Pergolizzi J, Raffa R, LeQuang JAK, Breve F, Varrassi G (2023) Old drugs and new challenges: a narrative review of nitazenes. Cureus 15:e40736
Schüller M, Lucic I, Oiestad AML, Pedersen-Bjergaard S, Oiestad EL (2023) High-throughput quantification of emerging nitazene benzimidazole opioid analogs by microextraction and UHPLC-MS-MS. J Anal Toxicol 47:787–796
Pucci M, Jutley GS, Looms J, Ford L (2024) N-desethylisotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kindom. Clin Toxicol 62:19–25
Bendjilali-Sabiani JJ, Levin T, Constans C, Legrand A, Descoeur J, Eiden C, Lossois M, Peyrière H, Mathieu O (2024) Exploration Toxicologique Du premier décès par isotonitazène identifié en France métropolitaine. Toxicol Anal Clin 36. https://doi.org/10.1016/j.toxac.2024.03.027
Kintz P, Groupe de travail de la SFTA (2024) Recommandations de la SFTA pour la réalisation des analyses toxicologiques impliquant des NPS – version 2024. Toxicol Anal Clin 36. https://doi.org/10.1016/j.toxac.2024.06.004
Giorgetti A, Brunetti P, Pelotti S, Auwärter V (2022) Detection of AP-237 and synthetic cannabinoids on an infused letter sent to a German prisoner. Drug Test Anal 14:1779–1784
Ameline A, Gheddar L, Pichini S, Stove C, Aknouche F, Maruejouls C, Raul JS, Kintz P (2024) In vitro characterization of protonitazene metabolites, using human liver microsomes, and first application to two urines collected from death cases. Clin Chim Acta 561:119764. https://doi.org/10.1016/j.cca.2024.119764
Klaassen CD (1988) Intestinal and hepatobiliary disposition of drugs. Toxicol Pathol 16:130–137
Mercurio I, Ceraso G, Melai P, Gili A, Troiano G, Agostinelli F, Lancia M, Bacci M (2019) Significance of morphine concentration in bile, liver, and blood: analysis of 52 cases of heroin overdoses. Am J Forensic Med Pathol 40:329–335
Anderson DT, Muto JJ (2000) Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol 24:627–634
Giorgetti A, Perdekamp MG, Franchetti G, Pircher R, Pollak S, Pelotti S, Auwärter V (2024) Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. Int J Leg Med Doi. https://doi.org/10.1007/s00414-024-03263-7
Salomone A, Galletto M, Massano M, Di Corcia D, Palamar JJ, Vincenti M (2023) Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations. J Forensic Sci 68:1698–1707
Bade R, Nadarajan D, Driver EM, Halden RU, Gerber C, Krotulski A, Hall W, Mueller JF (2024) Wastewater-based monitoring of the nitazene analogues: first detection of protonitazene in wastewater. Sci Total Environ 920:170781
Funding
The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Christophe Maruejouls: resources, project administration. Alice Ameline: methodology, investigation, formal analysis. Laurie Gheddar: methodology, investigation. Cédric Mazoyer: investigation, conceptualization. Kati Teston: investigation. Frédéric Aknouche: validation. Pascal Kintz: writing, review, editing.
Corresponding author
Ethics declarations
Ethical approval
This study does not need ethical approval.
Informed consent
Not required.
Conflict of interest
None declared (forensic expertise requested by the Prosecutor).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Maruejouls, C., Ameline, A., Gheddar, L. et al. First evidence in an oversea French department of the deadly risk of protonitazene use: about 5 post mortem cases. Int J Legal Med 139, 87–93 (2025). https://doi.org/10.1007/s00414-024-03309-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-024-03309-w